Bingfeng Liu

2.7k total citations
38 papers, 1.1k citations indexed

About

Bingfeng Liu is a scholar working on Virology, Immunology and Molecular Biology. According to data from OpenAlex, Bingfeng Liu has authored 38 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Virology, 11 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Bingfeng Liu's work include HIV Research and Treatment (13 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). Bingfeng Liu is often cited by papers focused on HIV Research and Treatment (13 papers), CAR-T cell therapy research (8 papers) and Immune Cell Function and Interaction (8 papers). Bingfeng Liu collaborates with scholars based in China, United States and Nigeria. Bingfeng Liu's co-authors include Hui Zhang, Chao Liu, Yijun Zhang, Fan Zou, Guannan Geng, Haihua Luo, Xiancai Ma, Jun Li, Weiping Cai and Yiwen Zhang and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Bingfeng Liu

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bingfeng Liu China 16 580 318 314 311 210 38 1.1k
Hiroyuki Yamamoto Japan 19 295 0.5× 458 1.4× 187 0.6× 158 0.5× 401 1.9× 62 1.1k
Bernadette Ferraro United States 14 460 0.8× 360 1.1× 275 0.9× 89 0.3× 76 0.4× 18 1.1k
Mani Larijani Canada 22 575 1.0× 656 2.1× 139 0.4× 60 0.2× 153 0.7× 48 1.2k
Agata Levay United States 16 751 1.3× 428 1.3× 161 0.5× 77 0.2× 41 0.2× 21 1.4k
Román Galetto United States 19 971 1.7× 210 0.7× 663 2.1× 62 0.2× 253 1.2× 51 1.6k
Maria Teresa Catanese United States 17 473 0.8× 275 0.9× 125 0.4× 204 0.7× 156 0.7× 24 1.9k
Danilo Pellin United States 14 714 1.2× 166 0.5× 178 0.6× 47 0.2× 93 0.4× 29 1.0k
Christopher S. Barker United States 13 550 0.9× 181 0.6× 128 0.4× 91 0.3× 151 0.7× 25 1.2k
Valentina Dell’Oste Italy 22 402 0.7× 633 2.0× 196 0.6× 97 0.3× 71 0.3× 49 1.3k

Countries citing papers authored by Bingfeng Liu

Since Specialization
Citations

This map shows the geographic impact of Bingfeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bingfeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bingfeng Liu more than expected).

Fields of papers citing papers by Bingfeng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bingfeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bingfeng Liu. The network helps show where Bingfeng Liu may publish in the future.

Co-authorship network of co-authors of Bingfeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Bingfeng Liu. A scholar is included among the top collaborators of Bingfeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bingfeng Liu. Bingfeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Tao, Xiaohui Deng, Jinsheng Zeng, et al.. (2025). The crosstalk between ubiquitination and GlcNAcylation of CHAF1A regulates HIV-1 latency and reactivation. Journal of Virology. 99(12). e0151825–e0151825.
3.
Zhang, Xu, Shiyu Wu, Yingtong Lin, et al.. (2025). Development of an Assay Evaluating the Inducible HIV‐1 Latent Reservoir Based on Reverse Transcription Droplet Digital PCR for Unspliced/Intact Viral RNA. Journal of Medical Virology. 97(3). e70295–e70295. 1 indexed citations
4.
Lu, Lidan, Bingfeng Liu, Yuhao Chen, et al.. (2024). The electronic and optical properties of group III-V semiconductors: Arsenides and Antimonides. Computational Materials Science. 246. 113381–113381. 4 indexed citations
5.
Chen, Cancan, Wanying Zhang, Baijin Xia, et al.. (2024). Tannic acid reactivates HIV-1 latency by mediating CBX4 degradation. Journal of Virology. 99(1). e0117324–e0117324.
6.
Yu, Fei, Yingshi Chen, Lingling Liu, et al.. (2024). Generation of a new therapeutic d-peptide that induces the differentiation of acute myeloid leukemia cells through A TLR-2 signaling pathway. Cell Death Discovery. 10(1). 51–51. 5 indexed citations
7.
Lin, Keming, Baijin Xia, Xuemei Wang, et al.. (2024). Development of nanobodies targeting hepatocellular carcinoma and application of nanobody-based CAR-T technology. Journal of Translational Medicine. 22(1). 349–349. 7 indexed citations
8.
9.
Fang, Qiannan, Yuanqiang Zhu, Xi Lv, et al.. (2024). Development of a PCSK9-targeted nanoparticle vaccine to effectively decrease the hypercholesterolemia. Cell Reports Medicine. 5(6). 101614–101614. 14 indexed citations
10.
Wang, Tingting, et al.. (2024). Adsorption behavior of poly(ethylene oxide) on kaolinite: Experimental and molecular simulation study. Physicochemical Problems of Mineral Processing. 1 indexed citations
11.
Yang, Tao, Ming Yuan, Xinyu Li, et al.. (2024). ORC1 enhances repressive epigenetic modifications on HIV-1 LTR to promote HIV-1 latency. Journal of Virology. 98(8). e0003524–e0003524. 4 indexed citations
12.
Zhang, Xiantao, Jie Liu, Ran Chen, et al.. (2023). A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages. Advanced Science. 10(27). e2301034–e2301034. 23 indexed citations
13.
Qiao, Yidan, Jie Chen, Xuemei Wang, et al.. (2023). Enhancement of CAR‐T cell activity against cholangiocarcinoma by simultaneous knockdown of six inhibitory membrane proteins. Cancer Communications. 43(7). 788–807. 36 indexed citations
14.
Xia, Baijin, Keming Lin, Xuemei Wang, et al.. (2023). Nanobody-derived bispecific CAR-T cell therapy enhances the anti-tumor efficacy of T cell lymphoma treatment. Molecular Therapy — Oncolytics. 30. 86–102. 18 indexed citations
15.
Zhang, Wanying, Mo Zhou, Cancan Chen, et al.. (2022). Identification of CD98 as a Novel Biomarker for HIV-1 Permissiveness and Latent Infection. mBio. 13(6). e0249622–e0249622. 6 indexed citations
16.
Zhang, Junsong, Jun Liu, Yaochang Yuan, et al.. (2020). Two waves of pro-inflammatory factors are released during the influenza A virus (IAV)-driven pulmonary immunopathogenesis. PLoS Pathogens. 16(2). e1008334–e1008334. 41 indexed citations
17.
Wu, Kang, Shao-ying Zhang, Xu Zhang, et al.. (2019). IL-21 Expands HIV-1-Specific CD8+ T Memory Stem Cells to Suppress HIV-1 Replication In Vitro. Journal of Immunology Research. 2019. 1–13. 5 indexed citations
18.
Zou, Fan, Lijuan Lu, Jun Liu, et al.. (2019). Engineered triple inhibitory receptor resistance improves anti-tumor CAR-T cell performance via CD56. Nature Communications. 10(1). 4109–4109. 92 indexed citations
19.
Zhang, Yiwen, Yingshi Chen, Jun Liu, et al.. (2017). A Cellular MicroRNA Facilitates Regulatory T Lymphocyte Development by Targeting the FOXP3 Promoter TATA-Box Motif. The Journal of Immunology. 200(3). 1053–1063. 33 indexed citations
20.
Li, Jun, Cancan Chen, Xiancai Ma, et al.. (2016). Long noncoding RNA NRON contributes to HIV-1 latency by specifically inducing tat protein degradation. Nature Communications. 7(1). 11730–11730. 149 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroyuki Yamamoto Breakdown of academic impact, for papers by Bernadette Ferraro Breakdown of academic impact, for papers by Mani Larijani Breakdown of academic impact, for papers by Agata Levay Breakdown of academic impact, for papers by Román Galetto Breakdown of academic impact, for papers by Maria Teresa Catanese Breakdown of academic impact, for papers by Danilo Pellin Breakdown of academic impact, for papers by Christopher S. Barker Breakdown of academic impact, for papers by Valentina Dell’Oste
Rankless by CCL
2026